跳至主要内容
临床试验/NCT02982304
NCT02982304Unknown1 期

Multi-Target Pallidal and Thalamic Deep Brain Stimulation for Hemi-Dystonia

University of British Columbia2 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
1 期
入组人数
4
试验地点
2
主要终点
Burke Fahn Marsden Disability Rating Scale (BFMDRS)

研究概览

简要总结

Dystonia is increasingly being considered as a multi-nodal network disorder involving both basal ganglia and cerebellar dysfunction. The aim of this study is to determine if "Multi-Target" Thalamic and Pallidal Deep Brain Stimulation improves hemi-dystonia patients who are receiving inadequate therapy from GPi DBS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with hemi-dystonia secondary to stroke
  • Candidate for GPi DBS
  • Able to provide informed consent

排除标准

  • History of intracranial pathology (such as multiple sclerosis, tumors, or aneurysms) that may account for dystonia or essential tremor.
  • History or evidence of ongoing psychiatric or neurodegenerative disorders (such as Parkinson's disease, Alzheimer's disease).
  • Incompetent adults or those unable to communicate.

结局指标

主要结局

Burke Fahn Marsden Disability Rating Scale (BFMDRS)

时间窗: 3 months

Adverse effects of Vim or Vim + GPi Neuromodulation

时间窗: 3 months

SF-36 Quality of Life Scale

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Honey

Principal Investigator

University of British Columbia

研究点 (2)

Loading locations...

相似试验